SPI Acquires Gonghe County Xinte Photovoltaic

Solar Power, Inc. (“SPI”), a vertically-integrated photovoltaic (“PV”) developer, today announced that it has entered into definitive agreements and closed the acquisition of Gonghe County Xinte Photovoltaic Co., Ltd. (“Xinte”), a PV project company established in the People’s Republic of China with limited liability and directly owned by TBEA Xinjiang Sunoasis Co., Ltd. (“TBEA Sunoasis”).

TBEA Sunoasis is a leading provider of PV products and system integration services and a subsidiary of TBEA Co., Ltd. (Shanghai: 600089), a top machinery maker in China according to the China Machinery Top 500 Research Report. As a result, SPI immediately adds to its global portfolio a solar PV project in the Ningxia Hui Autonomous Region of China with an annual nameplate capacity of 20 megawatts (MW).

Under the terms of the definitive agreements, SPI’s wholly owned subsidiary, SPI Solar Power (Suzhou) Co., Ltd., closed the transaction to acquire all of the outstanding capital stock of Xinte from TBEA Sunoasis for an aggregate purchase price of RMB206.0 million (U.S. $33.1 million) in cash and factoring financing. This transaction follows a framework agreement with TBEA Sunoasis previously announced on November 17, 2014, and SPI contemplates acquiring from TBEA Sunoasis an aggregate of 168.5 MW of solar PV projects across China pursuant to the framework agreement.

Mr. Xiaofeng Peng, Chairman of SPI, commented, “We are very pleased to announce completion of SPI’s acquisition of Xinte, which immediately adds 20 MW to our diversified, global PV portfolio. This acquisition marks another step in SPI’s ongoing efforts to take advantage of a rapidly expanding PV installation market across China.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.